Miscellaneous Disorders of Nutrition, Metabolism, Fluids and Electrolytes without MCC: Inpatient Reimbursement Overview

DRG 641 encompasses miscellaneous disorders of nutrition, metabolism, fluids and electrolytes without Major Complication or Comorbidity, including conditions such as mild electrolyte disturbances and nutritional deficiencies that do not meet higher-severity criteria. Understanding this Diagnosis-Related Group matters for inpatient reimbursement because it determines grouping and relative payment weight under Medicare's prospective payment system.

Customize your policy alerts

Sign up for drg 641 policy alerts

Get alerted when payer policies referencing 641 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

DRG 641 Overview

DRG 641 covers hospital stays for miscellaneous disorders of nutrition, metabolism, fluids and electrolytes without Major Complication or Comorbidity. Typical cases include electrolyte imbalances, malnutrition assessments, and metabolic disturbances that do not carry a Major Complication or Comorbidity. This Diagnosis-Related Group is relevant to inpatient payment because it groups clinically related cases with similar resource use for Medicare reimbursement. Accurate coding within this group influences assignment of payment weight and hospital revenue.

Explore openpayer tools

View all tools

Miscellaneous Disorders of Nutrition, Metabolism, Fluids and Electrolytes without MCC: Inpatient Reimbursement Overview

Customize your policy alerts

Sign up for drg 641 policy alerts

Get alerted when payer policies referencing 641 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

DRG 641 Overview

National Payment Rates

Across commercial payers the observed payment rates range roughly from $370 up to $27K, with commercial medians clustered around $12K–$14K in several plans. The widest spread is between BCBS (min ~$370, max $20K) and Anthem (min ~$390, max $27K), reflecting a payer-to-payer range of about $27K. See the table and chart below for payer-level detail.

The CMS 2023 data represent national Medicare fee-for-service inpatient payments reported under the CMS Provider Utilization and Payment Data program. The table below shows average total payment ($7.4k), average submitted covered charges ($34.7k), average Medicare payment ($5.6k), and total discharges (65.3k).

Average Total Payment	Average Submitted Charges	Average Medicare Payment	Total Discharges
$7.4K	$35K	$5.6K	65K

Patient Population

This DRG’s population is mixed but skews toward Medicare-age beneficiaries rather than exclusively working-age adults. Most discharges in CMS data reflect older adults enrolled in Medicare fee-for-service, while commercial payers cover a portion of younger, working-age patients. Expect a distribution with a substantial Medicare cohort alongside a smaller commercial cohort.

State Payment Rates

State: Alaska1 / 49

Alaska Benchmarks

Alaska’s mean reimbursement for DRG 641 ranges from $12K to $19K across payers, with Cigna at the high end and Blue Cross Blue Shield and Anthem at the low end. The state exhibits a relatively narrow payer spread but Cigna’s mean sits noticeably above the other state payers. This represents a meaningful deviation from national averages where means are generally lower or more varied for some payers. See the table and chart below for detailed payer-level benchmarks.

Key Insights for Alaska

Highest payer: Cigna at a mean of $19K; Lowest payers: Blue Cross Blue Shield and Anthem at a mean of $12K.
Alaska’s mean rates range from $12K to $19K, with Cigna notably above the other state payers and modestly higher than national means for some payers.

Clinical Trials

Acute electrolyte and fluid management trials: randomized or pragmatic studies evaluating rapid correction strategies for common inpatient electrolyte disturbances (such as severe hyponatremia, hyperkalemia, or symptomatic hypocalcemia) and protocols for intravenous fluid selection and dosing in hospitalized adults. These studies enroll patients admitted for acute metabolic derangements or dehydration who require urgent inpatient correction, and they compare safety endpoints such as rates of overcorrection, arrhythmia, and need for ICU transfer as well as short-term clinical recovery. Results inform inpatient clinical pathways and utilization of monitoring resources, which directly affect length of stay and cost drivers important to providers and payers for this DRG.
Comparative effectiveness and care-delivery studies for nutrition and glycemic management: prospective cohort studies or randomized comparative trials examining enteral versus parenteral nutrition strategies, timing of nutritional initiation, or differing inpatient glycemic control protocols in medically complex patients with malnutrition, prolonged NPO status, or steroid-induced hyperglycemia. These trials typically target general medicine inpatients with malnutrition risk or metabolic comorbidities and assess outcomes such as infection rates, wound healing, readmission, and total inpatient resource use. Findings help determine best practices that reduce complications and readmissions, thereby guiding reimbursement policies and care pathways for this heterogeneous group.
Post-discharge outcomes and transitional care research: observational and interventional studies focused on reducing readmissions and adverse events after discharge for patients treated for fluid, electrolyte, or metabolic disorders—examples include discharge monitoring programs, remote electrolyte surveillance, or pharmacist-led medication reconciliation for diuretics and potassium supplements. These studies follow patients after hospital discharge to measure readmission rates, ED visits, and outpatient resource utilization, often enrolling older adults or those with multiple comorbidities common in this DRG. Evidence from these studies supports care coordination interventions and payment models aimed at lowering post-discharge costs and improving quality metrics that affect provider reimbursement.

Adrenal and Pituitary Procedures with CC/MCC: Inpatient Reimbursement Overview

615-ADRENAL-AND-PITUITARY-PROCEDURES-WITHOUT-CC-MCC

Adrenal and Pituitary Procedures without CC/MCC: Inpatient Reimbursement Overview

616-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

617-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

618-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

619-O-R-PROCEDURES-FOR-OBESITY-WITH-MCC

O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

620-O-R-PROCEDURES-FOR-OBESITY-WITH-CC

O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

621-O-R-PROCEDURES-FOR-OBESITY-WITHOUT-CC-MCC

O.R. Procedures for Obesity without CC/MCC: Inpatient Reimbursement Overview

622-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

623-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

Showing 1–10 of 25

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Explore openpayer tools

View all tools

National Payment Rates

Mean Rates by Payer — National — DRG 641

Average Total Payment	Average Submitted Charges	Average Medicare Payment	Total Discharges
$7.4K	$35K	$5.6K	65K

Patient Population

State Payment Rates

State: Alaska1 / 49

Alaska Benchmarks

Mean Rates by Payer — Alaska — DRG 641

Key Insights for Alaska

Highest payer: Cigna at a mean of $19K; Lowest payers: Blue Cross Blue Shield and Anthem at a mean of $12K.
Alaska’s mean rates range from $12K to $19K, with Cigna notably above the other state payers and modestly higher than national means for some payers.

Clinical Trials

Acute electrolyte and fluid management trials: randomized or pragmatic studies evaluating rapid correction strategies for common inpatient electrolyte disturbances (such as severe hyponatremia, hyperkalemia, or symptomatic hypocalcemia) and protocols for intravenous fluid selection and dosing in hospitalized adults. These studies enroll patients admitted for acute metabolic derangements or dehydration who require urgent inpatient correction, and they compare safety endpoints such as rates of overcorrection, arrhythmia, and need for ICU transfer as well as short-term clinical recovery. Results inform inpatient clinical pathways and utilization of monitoring resources, which directly affect length of stay and cost drivers important to providers and payers for this DRG.
Comparative effectiveness and care-delivery studies for nutrition and glycemic management: prospective cohort studies or randomized comparative trials examining enteral versus parenteral nutrition strategies, timing of nutritional initiation, or differing inpatient glycemic control protocols in medically complex patients with malnutrition, prolonged NPO status, or steroid-induced hyperglycemia. These trials typically target general medicine inpatients with malnutrition risk or metabolic comorbidities and assess outcomes such as infection rates, wound healing, readmission, and total inpatient resource use. Findings help determine best practices that reduce complications and readmissions, thereby guiding reimbursement policies and care pathways for this heterogeneous group.
Post-discharge outcomes and transitional care research: observational and interventional studies focused on reducing readmissions and adverse events after discharge for patients treated for fluid, electrolyte, or metabolic disorders—examples include discharge monitoring programs, remote electrolyte surveillance, or pharmacist-led medication reconciliation for diuretics and potassium supplements. These studies follow patients after hospital discharge to measure readmission rates, ED visits, and outpatient resource utilization, often enrolling older adults or those with multiple comorbidities common in this DRG. Evidence from these studies supports care coordination interventions and payment models aimed at lowering post-discharge costs and improving quality metrics that affect provider reimbursement.

Adrenal and Pituitary Procedures with CC/MCC: Inpatient Reimbursement Overview

615-ADRENAL-AND-PITUITARY-PROCEDURES-WITHOUT-CC-MCC

Adrenal and Pituitary Procedures without CC/MCC: Inpatient Reimbursement Overview

616-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

617-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

618-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

619-O-R-PROCEDURES-FOR-OBESITY-WITH-MCC

O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

620-O-R-PROCEDURES-FOR-OBESITY-WITH-CC

O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

621-O-R-PROCEDURES-FOR-OBESITY-WITHOUT-CC-MCC

O.R. Procedures for Obesity without CC/MCC: Inpatient Reimbursement Overview

622-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

623-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

Showing 1–10 of 25

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

Miscellaneous Disorders of Nutrition, Metabolism, Fluids and Electrolytes without MCC: Inpatient Reimbursement Overview

Sign up for drg 641 policy alerts

DRG 641 Overview

OpenPayer

Miscellaneous Disorders of Nutrition, Metabolism, Fluids and Electrolytes without MCC: Inpatient Reimbursement Overview

Sign up for drg 641 policy alerts

DRG 641 Overview

National Payment Rates

Patient Population

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes

References

National Payment Rates

Patient Population

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes

References